Inari Medical
Avatar

CLOUT Interim Two-Year Outcomes

By Inari Medical FEATURING Angelo Marino, Andrew Niekamp
By Inari Medical FEATURING Angelo Marino, Andrew Niekamp
80 views
April 17, 2024

Dr. Angelo Marino details the CLOUT interim two-year outcomes and highlights his experience with the ClotTriever system.

0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
28:09
Inari Medical

Commitment to Innovation and Patient Outcomes: Advancement in VTE Pa…

Feat. K. Agrawal
11:09
Inari Medical

Experience using ClotTriever XL in IVC Thrombectomy

Feat. A. Niekamp, I. Raoli, A. misono
13:57
Inari Medical

Advancing VTE Patient Outcomes Through Innovation

Feat. W. Jaber
15:46
Inari Medical

Propensity-score Matched Analysis of Early Clinical Outcomes from th…

Feat. S. Abramowitz
09:40
Inari Medical

Evolution from Thrombolytic Therapy to Mechanical Thrombectomy for t…

Feat. K. Khalaf
09:55
Inari Medical

Safety and Effectiveness of the ClotTriever System for Treating Deep…

Feat. A. Shaikh
19:49
Rush University Medical Center

COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Feat. S. Jain
26:11
13th Orange County Symposium for Cardiovascular Disease Prevention

Update on Calcium Screening and CTA: Role in Prevention

Feat. M. Budoff
27:35
CHEST 2022 Coverage

Common Indoor Mold and Pulmonary Disease Associated With Them

Feat. S. Cherian
26:02
SIR 2024 Insights

SIR 2024 Insights: Advanced Management of Chronic Venous Obstruction

Feat. E. Azene
18:57
Leonie Heilbronn

2021 ADA Highlights: Impact of Intermittent Fasting on Health, Aging…

21:20
Cleveland Clinic Rheumatology

How do I Recognize and Treat the VEXAS Syndrome?

Feat. P. Grayson
16:19
James Douketis

Prevention and Treatment of Cancer-Associated Thrombosis: What Are t…

08:29
PERT Consortium 2022

Duration of Anticoagulation: Provoked vs Unprovoked VTE

Feat. G. Barnes
21:17
Venous Edge

Acute DVT: When to and When Not to Intervene?

Feat. S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
13:25
TCT 2022 Conference Coverage

TCT 2022: Why Intervene on Submassive Pulmonary Embolism Patients?

Feat. W. Jaber
26:38
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Outpatient DVT Prophylaxis in Oncology Patients: Who Should Get It a…

Feat. K. Martin
11:03
UC San Diego Health - Hemophilia and Thrombosis Treatment Center

Upper Extremity Point of Care Ultrasound (POCUS)

Feat. T. Sekayan
60:43
AVA 2022 Annual Scientific Meeting

Catheter Wars: The Thrombus Strikes Back

Feat. A. Bulmer, P. Carr
51:20
Jerry Spivak

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

16:54
NYU Langone

Management of Acute Pulmonary Embolism: How Long Do You Treat?

Feat. N. Amoroso
43:47
Michigan Medicine

Investigation and Management of Palpitations

Feat. M. Ghannam
31:23
13th Orange County Symposium for Cardiovascular Disease Prevention

Atherosclerosis Is an Inflammatory Disease

Feat. P. Toth
09:30
The Online Cardiac Catheterization Casebook

From a CTA right to a coronary Stent -Don't take the short cut.

Feat. M. Kern
18:12
Keck School of Medicine of USC

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for …

Feat. L. Clavijo